(Press-News.org) A novel two-pronged strategy targeting DNA synthesis can treat leukemia in mice, according to a study in The Journal of Experimental Medicine.
Current treatments for acute lymphoblastic leukemia (ALL), an aggressive form of blood cancer, include conventional chemotherapy drugs that inhibit DNA synthesis. These drugs are effective but have serious side effects on normal dividing tissues.
In order to replicate, cells must make copies of their DNA, which is made up of building blocks called deoxyribonucleotide triphosphates (dNTPs). Cells can either make dNTPs from scratch (the "de novo" pathway) or by picking up the breakdown products of cells death (the "salvage" pathway). Caius Radu and colleagues at the University of California, Los Angeles now show that blocking the de novo pathway using thymidine causes leukemia cells to switch to the salvage pathway. This may explain why thymidine showed limited effectiveness as a single agent in clinical trials. Blocking both the de novo and salvage pathways was lethal for leukemic cells. The authors also found that a novel small molecule inhibitor of the salvage pathway enzyme deoxycytidine kinase blocked leukemia growth in mice in combination with thymidine (to inhibit the de novo pathway). Importantly, there was no significant toxicity to normal blood cell development. Why leukemic cells and normal blood cell precursors respond so differently to this treatment requires further investigation.
According to Radu, "this new dual targeting approach shows that we can overcome the redundancy in DNA synthesis in ALL cells and identifies a potential target for metabolic intervention in ALL, and possibly in other hematological cancers."
This interdisciplinary study not only advances our understanding of DNA synthesis in leukemic cells but also identifies targeted metabolic intervention as a new therapeutic approach in ALL. Clinical trials will be required to establish whether these promising findings will translate into a new therapeutic approach for ALL.
INFORMATION:
Nathanson, D.A., et al. 2014. J. Exp. Med. doi:10.1084/jem.20131738
About The Journal of Experimental Medicine
The Journal of Experimental Medicine (JEM) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JEM content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jem.org .
Research reported in the press release was supported by the National Cancer Institute and the National Institutes of Health.
Two-pronged approach successfully targets DNA synthesis in leukemic cells
2014-02-24
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Blocking autophagy with malaria drug may help overcome resistance to melanoma BRAF drugs
2014-02-24
PHILADELPHIA— Half of melanoma patients with the BRAF mutation have a positive response to treatment with BRAF inhibitors, but nearly all of those patients develop resistance to the drugs and experience disease progression.
Now, a new preclinical study published online ahead of print in the Journal of Clinical Investigation from Penn Medicine researchers found that in many cases the root of the resistance may lie in a never-before-seen autophagy mechanism induced by the BRAF inhibitors vermurafenib and dabrafenib. Autophagy is a process by which cancer cells recycle ...
Like mom or dad? Some cells randomly express one parent's version of a gene over the other
2014-02-24
Cold Spring Harbor, NY – We are a product of our parents. Maybe you have your mother's large, dark eyes, and you inherited your father's infectious smile. Both parents contribute one copy, or allele, of each gene to their offspring, so that we have two copies of every gene for a given trait – one from mom, the other from dad. In general, both copies of a gene are switched on or off as an embryo develops into an adult. The "switching on" of a gene begins the process of gene expression that ultimately results in the production of a protein.
Occasionally, a cell will arbitrarily ...
Caring for patients with multiple chronic conditions -- New research and future challenges
2014-02-24
Philadelphia, Pa. (February 21, 2014) – The millions of Americans living with more than one chronic disease are at high risk of poor health outcomes, and account for a disproportionate share of health care costs. A special March supplement to Medical Care presents updates from the Agency for Healthcare Research and Quality's (AHRQ) Multiple Chronic Conditions (MCC) Research Network, formed to address knowledge gaps and research challenges in meeting the complex health care needs of this growing population. The journal is published by Lippincott Williams & Wilkins, a part ...
Nearly half of uninsured children live in immigrant families, reports study in Medical Care
2014-02-24
Philadelphia, Pa. (February 21, 2014) – Children from immigrant families now account for 42 percent of uninsured children in the United States, reports a study in the March issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
More than two-thirds of uninsured children with immigrant parents are US citizens, according to an analysis of nationwide survey data by Eric E. Seiber, PhD, of The Ohio State University College of Public Health, Columbus. He writes, "Initiatives to expand coverage or increase Medicaid ...
Preventing suicide should start in a general medical setting
2014-02-24
The mental health conditions of most people who commit suicide remain undiagnosed, even though most visit a primary care provider or medical specialist in the year before they die. To help prevent suicides, health care providers should therefore become more attuned to their patients' mental health state and possible suicide ideation. These are the findings of Brian Ahmedani from the Henry Ford Health System in Detroit, Michigan, in a new study¹ documenting the type and timing of health services sought by Americans who commit suicide. The study is the largest geographically ...
Did you hear the one about the doctor?
2014-02-24
LEBANON, NH (Feb. 24, 2014) – In a study that demonstrates the potential of using social networking sites for research on health and medicine, Dartmouth researchers studied jokes made about doctors posted on Facebook.
"Social networking sites, such as Facebook, have become immensely popular in recent years and present a unique opportunity for researchers to eavesdrop on the collective conversation of current societal issues," said Matthew Davis of The Dartmouth Institute of Health Policy & Clinical Practice.
In one of the first studies of social networking site conversations ...
Exclusive David Gancberg article in Human Gene Therapy
2014-02-24
New Rochelle, NY, February 24, 2014—Over the past three funding stages, the European Commission has invested nearly $475 million in 100 projects in the gene transfer and gene therapy field. David Gancberg, Directorate-General for Research and Innovation, European Commission (Brussels), describes the substantial opportunities for funding to support basic and clinical research in gene and cell therapy to find new treatments for chronic and rare diseases and novel regenerative medicine approaches in a Commentary article in Human Gene Therapy, a peer-reviewed journal from Mary ...
Volcanoes contribute to recent warming 'hiatus'
2014-02-24
LIVERMORE, Calif. -- Volcanic eruptions in the early part of the 21st century have cooled the planet, according to a study led by Lawrence Livermore National Laboratory. This cooling partly offset the warming produced by greenhouse gases.
Despite continuing increases in atmospheric levels of greenhouse gases, and in the total heat content of the ocean, global-mean temperatures at the surface of the planet and in the troposphere (the lowest portion of the Earth's atmosphere) have shown relatively little warming since 1998. This so-called 'slow-down' or 'hiatus' has received ...
Personalized medicine best way to treat cancer, study argues
2014-02-24
If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient's cancer treatment on commonly disrupted genes and pathways.
The study found little or no overlap in the most prominent genetic malfunction associated with each individual patient's disease compared to malfunctions ...
On the road to Mottronics
2014-02-24
"Mottronics" is a term seemingly destined to become familiar to aficionados of electronic gadgets. Named for the Nobel laureate Nevill Francis Mott, Mottronics involve materials – mostly metal oxides - that can be induced to transition between electrically conductive and insulating phases. If these phase transitions can be controlled, Mott materials hold great promise for future transistors and memories that feature higher energy efficiencies and faster switching speeds than today's devices. A team of researchers working at Berkeley Lab's Advanced Light Source (ALS) have ...